Filippo Filicori1,2, Christy M Dunst3,4, Ahmed Sharata1,2, Walaa F Abdelmoaty1,2, Ahmed M Zihni1,2, Kevin M Reavis1,2, Steven R Demeester1,2, Lee L Swanström1,5,2. 1. Gastrointestinal and Minimally Invasive Surgery Division, The Oregon Clinic, 3805 NE Glisan St, Suite 6N60, Portland, OR, 97213, USA. 2. Foundation for Surgical Innovation and Education, 4805 NE Glisan St, Suite 6N60, Portland, OR, 97213, USA. 3. Gastrointestinal and Minimally Invasive Surgery Division, The Oregon Clinic, 3805 NE Glisan St, Suite 6N60, Portland, OR, 97213, USA. cdunst@orclinic.com. 4. Foundation for Surgical Innovation and Education, 4805 NE Glisan St, Suite 6N60, Portland, OR, 97213, USA. cdunst@orclinic.com. 5. Institut Hospitalo Universitaire Strasbourg, 1, Place de l'Hôpital, 97000, Strasbourg, France.
Abstract
BACKGROUND: Optimal treatment for symptomatic patients with non-achalasia motility disorders (NAD) such as diffuse esophageal spasm, esophagogastric junction outlet obstruction, and hypercontractile disorder is not well established. POEM has been offered to these patients since it is a less invasive and less morbid procedure but long-term outcomes remain undetermined. The aim of this study was to assess long-term outcomes of POEM for patients with NAD. METHODS: Records of 40 consecutive patients undergoing POEM for NAD from May 2011 to January 2016 at a single center were retrospectively reviewed. Preoperative and 6-month postoperative symptom scores, high-resolution manometry, pH testing, and timed barium swallow (TBS) data were collected. Patients were contacted by phone to obtain long-term symptom assessment. Symptoms were assessed using a standardized symptom questionnaire with scores for symptoms graded according to frequency and the Eckardt score. RESULTS: Ten percent had minor complications with no postoperative sequelae. 90% of patients had significant improvement in their mean Eckardt scores (5.02 vs. 1.12, p < 0.001) at early follow-up. Improvements in chest pain (1.02-0.36, p = 0.001) and dysphagia (2.20 vs. 0.40, p = 0.001) were seen. Significant improvements in manometric pressures and esophageal emptying on TBS were observed across groups. 38% (10/26) of patients had a postoperative pH score > 14.72. Long-term (median 48 months) symptom scores were obtained from 29 (72.5%) patients. 82% of patients (24/29) had sustained symptom improvement. A small increase in the dysphagia scores was reported in the long-term follow-up compared to the immediate postoperative period (0.36-0.89, p = 0.046). CONCLUSIONS: Chest pain and dysphagia are effectively palliated with POEM in patients with non-achalasia disorders of the esophagus. Significant improvements are durable in long-term follow-up. Despite earlier reports by our group suggesting possible inferior outcomes from POEM for this difficult group of patients, this study is far more encouraging. POEM should be considered in the treatment of patients with non-achalasia disorders of the esophagus.
BACKGROUND: Optimal treatment for symptomatic patients with non-achalasia motility disorders (NAD) such as diffuse esophageal spasm, esophagogastric junction outlet obstruction, and hypercontractile disorder is not well established. POEM has been offered to these patients since it is a less invasive and less morbid procedure but long-term outcomes remain undetermined. The aim of this study was to assess long-term outcomes of POEM for patients with NAD. METHODS: Records of 40 consecutive patients undergoing POEM for NAD from May 2011 to January 2016 at a single center were retrospectively reviewed. Preoperative and 6-month postoperative symptom scores, high-resolution manometry, pH testing, and timed barium swallow (TBS) data were collected. Patients were contacted by phone to obtain long-term symptom assessment. Symptoms were assessed using a standardized symptom questionnaire with scores for symptoms graded according to frequency and the Eckardt score. RESULTS: Ten percent had minor complications with no postoperative sequelae. 90% of patients had significant improvement in their mean Eckardt scores (5.02 vs. 1.12, p < 0.001) at early follow-up. Improvements in chest pain (1.02-0.36, p = 0.001) and dysphagia (2.20 vs. 0.40, p = 0.001) were seen. Significant improvements in manometric pressures and esophageal emptying on TBS were observed across groups. 38% (10/26) of patients had a postoperative pH score > 14.72. Long-term (median 48 months) symptom scores were obtained from 29 (72.5%) patients. 82% of patients (24/29) had sustained symptom improvement. A small increase in the dysphagia scores was reported in the long-term follow-up compared to the immediate postoperative period (0.36-0.89, p = 0.046). CONCLUSIONS:Chest pain and dysphagia are effectively palliated with POEM in patients with non-achalasia disorders of the esophagus. Significant improvements are durable in long-term follow-up. Despite earlier reports by our group suggesting possible inferior outcomes from POEM for this difficult group of patients, this study is far more encouraging. POEM should be considered in the treatment of patients with non-achalasia disorders of the esophagus.
Authors: P J Kahrilas; A J Bredenoord; M Fox; C P Gyawali; S Roman; A J P M Smout; J E Pandolfino Journal: Neurogastroenterol Motil Date: 2014-12-03 Impact factor: 3.598
Authors: An Moonen; Vito Annese; Ann Belmans; Albert J Bredenoord; Stanislas Bruley des Varannes; Mario Costantini; Bertrand Dousset; J I Elizalde; Uberto Fumagalli; Marianne Gaudric; Antonio Merla; Andre J Smout; Jan Tack; Giovanni Zaninotto; Olivier R Busch; Guy E Boeckxstaens Journal: Gut Date: 2015-11-27 Impact factor: 23.059
Authors: Ahmed Sharata; Ashwin A Kurian; Christy M Dunst; Neil H Bhayani; Kevin M Reavis; Lee L Swanstrom Journal: Surg Endosc Date: 2014-02-26 Impact factor: 4.584
Authors: Sarah C McKay; Christy M Dunst; Ahmed M Sharata; Reid Fletcher; Kevin M Reavis; Daniel Davila Bradley; Steven R DeMeester; Dolores Müller; Brett Parker; Lee L Swanström Journal: Surg Endosc Date: 2021-01-04 Impact factor: 4.584
Authors: Lena Shally; Kashif Saeed; Derek Berglund; Mark Dudash; Katie Frank; Vladan N Obradovic; Anthony T Petrick; David L Diehl; Jon D Gabrielsen; David M Parker Journal: Surg Endosc Date: 2022-10-11 Impact factor: 3.453
Authors: Ryan A J Campagna; Arturo Cirera; Amy L Holmstrom; Joseph R Triggs; Ezra N Teitelbaum; Dustin A Carlson; John E Pandolfino; Eric S Hungness Journal: Ann Surg Date: 2021-06-01 Impact factor: 13.787
Authors: Alex Ju Sung Kim; Sungmoon Ong; Ji Hyun Kim; Hong Sub Lee; Jun Sik Yoon; Dae Young Hur Journal: J Neurogastroenterol Motil Date: 2022-01-30 Impact factor: 4.924
Authors: R A B Oude Nijhuis; G Zaninotto; S Roman; G E Boeckxstaens; P Fockens; M W Langendam; A A Plumb; Ajpm Smout; E M Targarona; A S Trukhmanov; Blam Weusten; Albert J Bredenoord Journal: United European Gastroenterol J Date: 2020-02 Impact factor: 4.623